Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Twinings Branch	4.62B	-	-	-	3.23B
Botai Branch	2.06B	-	-	-	-
Other Business Segments	12.15B	-	-	-	14.20B
Intersegment Offset	-308.54M	-	-	-	-150.51M
Total	18.51B	-	-	-	17.28B
Total Growth	-	-	-	-	4.94%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South China	1.47B	1.39B	1.17B	1.31B	1.42B
South China Growth	5.52%	19.53%	-10.78%	-7.93%	7.37%
North-East Region	630.79M	751.91M	832.96M	800.21M	885.51M
North-East Region Growth	-16.11%	-9.73%	4.09%	-9.63%	-5.17%
Northern China	1.72B	2.31B	2.24B	2.23B	2.16B
Northern China Growth	-25.58%	3.27%	0.63%	2.88%	13.94%
Eastern China	5.08B	5.71B	5.44B	4.34B	3.64B
Eastern China Growth	-10.92%	4.94%	25.22%	19.25%	4.80%
Central China	2.24B	2.82B	3.09B	3.44B	3.31B
Central China Growth	-20.54%	-8.80%	-10.01%	3.75%	9.86%
North-West China	1.10B	1.31B	1.25B	1.03B	972.32M
North-West China Growth	-16.01%	4.56%	21.82%	5.84%	-13.83%
Southwest China	3.78B	4.63B	4.84B	4.50B	3.98B
Southwest China Growth	-18.44%	-4.40%	7.70%	13.01%	4.13%
International Business	2.49B	2.89B	2.59B	1.40B	903.85M
International Business Growth	-13.79%	11.49%	84.80%	54.95%	3.84%
Total	18.51B	21.81B	21.45B	19.04B	17.28B
Total Growth	-15.13%	1.67%	12.69%	10.19%	4.94%

Source: S&P Global Market Intelligence.